Broad gets $650m for psychiatric genomic research, hopes pharma joins effort
This article was originally published in Scrip
Executive Summary
Philanthropist Ted Stanley made a multi-year $650m commitment to fund genomic research at the Eli and Edythe L Broad Institute in collaboration with scientists around the world that may generate biological pathways and molecules that could reignite pharmaceutical company interest in schizophrenia, bipolar disorder and other psychiatric conditions.